Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Genome partitioning of genetic variation for complex traits using common SNPs.
|
Nat Genet
|
2011
|
8.57
|
2
|
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.
|
Nat Genet
|
2008
|
6.10
|
3
|
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.
|
J Clin Oncol
|
2002
|
5.91
|
4
|
The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.
|
Nat Genet
|
2002
|
4.54
|
5
|
Common variants at 19p13 are associated with susceptibility to ovarian cancer.
|
Nat Genet
|
2010
|
4.51
|
6
|
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
|
Nat Genet
|
2009
|
4.38
|
7
|
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
|
Nat Genet
|
2013
|
4.35
|
8
|
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
|
Nat Genet
|
2010
|
3.86
|
9
|
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study.
|
Lancet Oncol
|
2010
|
3.49
|
10
|
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
|
Nat Genet
|
2013
|
3.42
|
11
|
BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair.
|
Cancer Res
|
2003
|
3.39
|
12
|
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.
|
Nat Genet
|
2011
|
3.16
|
13
|
Nonparametric tests of association of multiple genes with human disease.
|
Am J Hum Genet
|
2005
|
2.87
|
14
|
Two common chromosome 8q24 variants are associated with increased risk for prostate cancer.
|
Cancer Res
|
2007
|
2.56
|
15
|
Caution on pedigree haplotype inference with software that assumes linkage equilibrium.
|
Am J Hum Genet
|
2002
|
2.51
|
16
|
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
|
Lancet Oncol
|
2013
|
2.48
|
17
|
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.
|
Nat Genet
|
2010
|
2.37
|
18
|
Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states.
|
BMC Cancer
|
2009
|
2.32
|
19
|
Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility Loci.
|
Am J Hum Genet
|
2004
|
2.31
|
20
|
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
|
Blood
|
2007
|
2.31
|
21
|
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.
|
Clin Cancer Res
|
2011
|
2.09
|
22
|
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics.
|
Am J Hum Genet
|
2005
|
1.96
|
23
|
Mutations in CHEK2 associated with prostate cancer risk.
|
Am J Hum Genet
|
2003
|
1.96
|
24
|
hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling.
|
Gastroenterology
|
2004
|
1.95
|
25
|
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer.
|
Cancer Res
|
2007
|
1.92
|
26
|
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
|
Nat Genet
|
2013
|
1.85
|
27
|
Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene.
|
Clin Cancer Res
|
2009
|
1.83
|
28
|
Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.
|
Blood
|
2010
|
1.79
|
29
|
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
|
Nat Commun
|
2013
|
1.73
|
30
|
miRNA expression in colon polyps provides evidence for a multihit model of colon cancer.
|
PLoS One
|
2011
|
1.72
|
31
|
Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics.
|
Hum Genet
|
2006
|
1.70
|
32
|
Gene networks and microRNAs implicated in aggressive prostate cancer.
|
Cancer Res
|
2009
|
1.68
|
33
|
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.
|
Cancer Res
|
2011
|
1.64
|
34
|
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.
|
Gynecol Oncol
|
2013
|
1.61
|
35
|
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.
|
Cancer Res
|
2009
|
1.59
|
36
|
The presence of tandem endothelial nitric oxide synthase gene polymorphisms identifying brain aneurysms more prone to rupture.
|
J Neurosurg
|
2005
|
1.49
|
37
|
Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk.
|
Cancer Res
|
2008
|
1.49
|
38
|
Mitochondrial genetic polymorphisms and pancreatic cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.48
|
39
|
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
|
PLoS Genet
|
2010
|
1.47
|
40
|
Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.43
|
41
|
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.
|
Cancer Res
|
2013
|
1.43
|
42
|
Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.
|
Cancer Res
|
2008
|
1.42
|
43
|
Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study.
|
Hum Mol Genet
|
2009
|
1.42
|
44
|
Analysis of the RNASEL gene in familial and sporadic prostate cancer.
|
Am J Hum Genet
|
2002
|
1.41
|
45
|
Human SULT1A1 gene: copy number differences and functional implications.
|
Hum Mol Genet
|
2006
|
1.37
|
46
|
The genomic landscape of small intestine neuroendocrine tumors.
|
J Clin Invest
|
2013
|
1.37
|
47
|
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
|
Nat Commun
|
2013
|
1.36
|
48
|
Genome-wide transcriptional profiling reveals microRNA-correlated genes and biological processes in human lymphoblastoid cell lines.
|
PLoS One
|
2009
|
1.35
|
49
|
Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes.
|
J Infect Dis
|
2006
|
1.35
|
50
|
Inherited determinants of ovarian cancer survival.
|
Clin Cancer Res
|
2010
|
1.32
|
51
|
Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy.
|
Clin Cancer Res
|
2011
|
1.32
|
52
|
Comparison of the DNA methylation profiles of human peripheral blood cells and transformed B-lymphocytes.
|
Hum Genet
|
2010
|
1.31
|
53
|
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.
|
Blood
|
2012
|
1.26
|
54
|
Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer.
|
Cancer Res
|
2007
|
1.26
|
55
|
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.26
|
56
|
Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors.
|
J Allergy Clin Immunol
|
2007
|
1.24
|
57
|
Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.22
|
58
|
Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk.
|
Chest
|
2005
|
1.20
|
59
|
A rigorous and comprehensive validation: common genetic variations and lung cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.18
|
60
|
Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma.
|
Int J Mol Epidemiol Genet
|
2011
|
1.17
|
61
|
Polymorphisms in mitochondrial genes and prostate cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.17
|
62
|
Assessment of hepatocyte growth factor in ovarian cancer mortality.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.14
|
63
|
Functional and clinical significance of variants localized to 8q24 in colon cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.11
|
64
|
Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.11
|
65
|
The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study.
|
J Hum Genet
|
2008
|
1.10
|
66
|
CYP2C19 variation and citalopram response.
|
Pharmacogenet Genomics
|
2011
|
1.09
|
67
|
Genetic susceptibility variants for chronic lymphocytic leukemia.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.09
|
68
|
ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.08
|
69
|
Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.
|
Ann Neurol
|
2014
|
1.06
|
70
|
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.02
|
71
|
Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.01
|
72
|
Haplotype analysis improves molecular diagnostics of autosomal recessive polycystic kidney disease.
|
Am J Kidney Dis
|
2005
|
1.01
|
73
|
Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome.
|
Int J Mol Epidemiol Genet
|
2011
|
1.00
|
74
|
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
|
Hum Genet
|
2013
|
0.99
|
75
|
Ovarian cancer risk associated with inherited inflammation-related variants.
|
Cancer Res
|
2012
|
0.98
|
76
|
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel.
|
Hum Mol Genet
|
2013
|
0.97
|
77
|
Susceptibility genes and B-chronic lymphocytic leukaemia.
|
Br J Haematol
|
2007
|
0.97
|
78
|
Evaluation of clustering and genotype distribution for replication in genome wide association studies: the age-related eye disease study.
|
PLoS One
|
2008
|
0.95
|
79
|
Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
|
BMC Cancer
|
2012
|
0.94
|
80
|
MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.94
|
81
|
Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer.
|
BMC Cancer
|
2009
|
0.93
|
82
|
No association of germline alteration of MSR1 with prostate cancer risk.
|
Nat Genet
|
2003
|
0.93
|
83
|
Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study.
|
Physiol Genomics
|
2012
|
0.93
|
84
|
Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22.
|
PLoS One
|
2012
|
0.93
|
85
|
Inherited variants in regulatory T cell genes and outcome of ovarian cancer.
|
PLoS One
|
2013
|
0.93
|
86
|
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.92
|
87
|
Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk.
|
Lung Cancer
|
2010
|
0.92
|
88
|
Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke.
|
Cancer Discov
|
2011
|
0.92
|
89
|
Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.92
|
90
|
Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia.
|
Prostate
|
2006
|
0.91
|
91
|
Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.
|
Clin Cancer Res
|
2011
|
0.91
|
92
|
Common variants in PARK loci and related genes and Parkinson's disease.
|
Mov Disord
|
2010
|
0.90
|
93
|
Pharmacogenomics of antidepressant induced mania: a review and meta-analysis of the serotonin transporter gene (5HTTLPR) association.
|
J Affect Disord
|
2011
|
0.90
|
94
|
Risk of ovarian cancer and inherited variants in relapse-associated genes.
|
PLoS One
|
2010
|
0.90
|
95
|
Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study.
|
Parkinsonism Relat Disord
|
2009
|
0.90
|
96
|
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
|
J Natl Cancer Inst
|
2015
|
0.90
|
97
|
ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium.
|
Cancer Causes Control
|
2012
|
0.90
|
98
|
Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk.
|
Hum Genet
|
2014
|
0.89
|
99
|
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.
|
Cancer Res
|
2013
|
0.89
|
100
|
Coffee, caffeine-related genes, and Parkinson's disease: a case-control study.
|
Mov Disord
|
2008
|
0.89
|
101
|
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.89
|
102
|
Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia.
|
Am J Epidemiol
|
2004
|
0.89
|
103
|
Microsatellite instability in hereditary and sporadic breast cancers.
|
Int J Cancer
|
2003
|
0.88
|
104
|
Interaction of SLC6A4 and DRD2 polymorphisms is associated with a history of delirium tremens.
|
Addict Biol
|
2010
|
0.88
|
105
|
Identification of a novel percent mammographic density locus at 12q24.
|
Hum Mol Genet
|
2012
|
0.88
|
106
|
Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men.
|
Urology
|
2006
|
0.88
|
107
|
Germline copy number variation and ovarian cancer survival.
|
Front Genet
|
2012
|
0.88
|
108
|
Identification of novel variants in colorectal cancer families by high-throughput exome sequencing.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.88
|
109
|
The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.
|
J Hepatol
|
2008
|
0.87
|
110
|
Genomic determinants of motor and cognitive outcomes in Parkinson's disease.
|
Parkinsonism Relat Disord
|
2012
|
0.87
|
111
|
SEPT9 mutations and a conserved 17q25 sequence in sporadic and hereditary brachial plexus neuropathy.
|
Arch Neurol
|
2009
|
0.87
|
112
|
Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer.
|
Twin Res Hum Genet
|
2010
|
0.87
|
113
|
Mitochondrial genetic polymorphisms do not predict survival in patients with pancreatic cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.87
|
114
|
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.86
|
115
|
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
|
Mol Carcinog
|
2010
|
0.86
|
116
|
Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer.
|
BMC Med Genomics
|
2014
|
0.86
|
117
|
Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based study.
|
J Thorac Oncol
|
2009
|
0.85
|
118
|
Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH.
|
Prostate
|
2005
|
0.85
|
119
|
Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.85
|
120
|
UCHL1 is associated with Parkinson's disease: a case-unaffected sibling and case-unrelated control study.
|
Neurosci Lett
|
2005
|
0.85
|
121
|
Beta-synuclein gene variants and Parkinson's disease: a preliminary case-control study.
|
Neurosci Lett
|
2007
|
0.85
|
122
|
Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states.
|
Int J Neuropsychopharmacol
|
2012
|
0.85
|
123
|
Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform.
|
BMC Med Genomics
|
2010
|
0.84
|
124
|
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.84
|
125
|
Inflammation-related gene variants as risk factors for pancreatic cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.84
|
126
|
Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer.
|
Cancer Prev Res (Phila)
|
2011
|
0.84
|
127
|
Variants in estrogen-related genes and risk of Parkinson's disease.
|
Mov Disord
|
2011
|
0.84
|
128
|
Single nucleotide polymorphisms associated with abnormal coronary microvascular function.
|
Coron Artery Dis
|
2014
|
0.84
|
129
|
Replication of genome wide association studies of alcohol dependence: support for association with variation in ADH1C.
|
PLoS One
|
2013
|
0.84
|
130
|
Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer.
|
Gynecol Oncol
|
2009
|
0.84
|
131
|
Plasticity of DNA methylation in a nerve injury model of pain.
|
Epigenetics
|
2015
|
0.83
|
132
|
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.
|
Cancer Immunol Res
|
2014
|
0.82
|
133
|
Association of GATA4 sequence variation with alcohol dependence.
|
Addict Biol
|
2012
|
0.82
|
134
|
Survival is associated with genetic variation in inflammatory pathway genes among patients with resected and unresected pancreatic cancer.
|
Ann Surg
|
2013
|
0.82
|
135
|
Gluthatione-S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer.
|
Cancer Genet Cytogenet
|
2004
|
0.82
|
136
|
Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer.
|
Genet Epidemiol
|
2014
|
0.82
|
137
|
Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?
|
Parkinsonism Relat Disord
|
2011
|
0.81
|
138
|
Evaluating the influence of quality control decisions and software algorithms on SNP calling for the affymetrix 6.0 SNP array platform.
|
Hum Hered
|
2011
|
0.81
|
139
|
Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.80
|
140
|
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
|
Cancer Immunol Immunother
|
2013
|
0.80
|
141
|
Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes.
|
Br J Haematol
|
2012
|
0.80
|
142
|
Polymorphisms in metabolism/antioxidant genes may mediate the effect of dietary intake on pancreatic cancer risk.
|
Pancreas
|
2013
|
0.79
|
143
|
Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort.
|
Fertil Steril
|
2010
|
0.79
|
144
|
Luteinizing hormone beta polymorphism and risk of familial and sporadic prostate cancer.
|
Prostate
|
2003
|
0.78
|
145
|
Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium.
|
PLoS One
|
2011
|
0.78
|
146
|
FCGR2A and FCGR3A polymorphisms in classical Hodgkin lymphoma by Epstein-Barr virus status.
|
Leuk Lymphoma
|
2013
|
0.78
|
147
|
Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria.
|
Arch Neurol
|
2011
|
0.78
|
148
|
Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.78
|
149
|
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.
|
Mol Nutr Food Res
|
2014
|
0.77
|
150
|
Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.
|
Parkinsonism Relat Disord
|
2013
|
0.77
|
151
|
Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma.
|
Front Genet
|
2012
|
0.76
|
152
|
Linkage analysis of obesity phenotypes in pre- and post-menopausal women from a United States mid-western population.
|
BMC Med Genet
|
2010
|
0.75
|
153
|
Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.
|
Nat Genet
|
2015
|
0.75
|
154
|
Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.75
|
155
|
Association of TNFSF8 polymorphisms with peripheral neutrophil count.
|
Mayo Clin Proc
|
2011
|
0.75
|
156
|
No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density.
|
Breast Cancer Res
|
2012
|
0.75
|
157
|
Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome.
|
BMC Med Genomics
|
2014
|
0.75
|
158
|
Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant.
|
Mayo Clin Proc
|
2010
|
0.75
|
159
|
Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.
|
Am J Epidemiol
|
2016
|
0.75
|
160
|
Corrigendum: Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.
|
Nat Commun
|
2015
|
0.75
|